HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lifen Ren-Heidenreich Selected Research

Antigens

3/2004Redirected T-cell cytotoxicity to epithelial cell adhesion molecule-overexpressing adenocarcinomas by a novel recombinant antibody, E3Bi, in vitro and in an animal model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lifen Ren-Heidenreich Research Topics

Disease

5Neoplasms (Cancer)
11/2013 - 10/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2013 - 09/2012
2Colorectal Neoplasms (Colorectal Cancer)
08/2010 - 10/2002
1Lung Neoplasms (Lung Cancer)
11/2013
1Retinoblastoma (Glioblastoma, Retinal)
12/2004
1Adenocarcinoma
03/2004

Drug/Important Bio-Agent (IBA)

3Formaldehyde (Formol)FDA Link
09/2012 - 08/2010
3ParaffinIBA
09/2012 - 08/2010
2DNA (Deoxyribonucleic Acid)IBA
11/2013 - 02/2011
2Tyrosine Kinase InhibitorsIBA
11/2013 - 02/2011
2ErbB Receptors (EGF Receptor)IBA
11/2013 - 02/2011
2Epithelial Cell Adhesion MoleculeIBA
12/2004 - 03/2004
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2013
1Monoclonal AntibodiesIBA
12/2004
1Interleukin-2 (IL2)IBA
03/2004
1AntigensIBA
03/2004
1Chimeric Antigen ReceptorsIBA
10/2002
1Neoplasm Antigens (Tumor Antigens)IBA
10/2002
1zeta chain antigen T cell receptor (TCR zeta chain)IBA
10/2002
1CytokinesIBA
10/2002

Therapy/Procedure

2Therapeutics
02/2011 - 12/2004
1Immunotherapy
10/2002